SEC Form 4 · accession 0001093557-19-000034
DEXCOM INC · DXCM
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark G Foletta
Director
Period of report
Feb 15, 2019
Accepted (ET)
Feb 20, 2019 · 5:01 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001093557
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Feb 15, 2019 | S | 800 | $148.5238 | D | 16,295 | I | by Trust |
| Common StockF1,F4,F3 | Feb 15, 2019 | S | 200 | $149.52 | D | 16,095 | I | by Trust |
| Common Stock | holding | — | — | — | 4,052 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On December 13, 2018, Mr. Foletta adopted a 10b5-1 Plan. This 10b5-1 Plan allows the orderly disposition of shares owned by Mr. Foletta. The shares set forth above were sold pursuant to the 10b5-1 Plan.
- F2This transaction was executed in multiple trades at prices ranging from $147.94 to $148.83. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.
- F3Shares are held by the Mark G. and Mary E. Foletta, TTEE's for the Foletta Family Trust DTD 1/30/15, with respect to which the reporting person is a trustee.
- F4This transaction was executed in multiple trades at prices ranging from $149.41 to $149.63. The price above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transactions were effected.